Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific antibodies against CEACAM5 and CD3

Bispecific antibodies against CEACAM5 and CD3

US Patent 12441807 · Granted Oct 14, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific antibodies against CD3EPSILON and ROR12024
Bispecific antibodies against CEACAM5 and CD472023
Bispecific antibody against BCMA and CD3 and an immunological drug for combined 2021
Method for the selection of antibodies against BCMA2020
Monoclonal antibodies against BCMA2020
Bispecific antibodies against CD3ϵ and BCMA2019
Bispecific antibodies against CD3 and BCMA2018
Method for the selection of antibodies against BCMA2018
Use of carbazole compounds for the treatment of congestive heart failure2009
Method of treatment for decreasing mortality resulting from congestive heart fai2008
Use of carbazole compounds for the treatment of congestive heart failure1999
Parathormone fragments, their preparation and medicaments containing these1998